 Drug induced liver injury is a major reason for compound drop-out during drug development.
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Highlights
 Drug induced liver injury is a major reason for compound drop-out during drug development.
 Xenopus embryos provide a useful in vivo model to study drug toxicity.
 Xenopus embryos exhibit similar reactions to paracetamol induced liver injury observed in mammalian models.
Astract
Introduction: Failure to predict drug-induced liver injury (DILI) remains a major contributing factor to lead compound drop-out during drug development. Xenopus embryos are amenable for early stage medium throughput small molecule screens and so have the potential to be used in pre-clinical screens. To begin to assess the usefulness and limitations of Xenopus embryos for safety assessment in the early phases of drug development, paracetamol was used as a model hepatotoxin.
A C C E P T E D M
A N U S C R I P T
Introduction
Paracetamol is a frequently used antipyretic and analgesic drug that is safe at the therapeutic dose, which is 4 g/day. However, it exhibits dose-dependent hepatotoxicity and severe liver injury can occur when a single dose of 10-15 g of paracetamol is taken (1, 2) . Paracetamol contributes to 80 % of the liver failure cases associated with drugs A C C E P T E D M A N U S C R I P T (3) . It is the single largest cause of acute liver failure in the US and the UK and the second most common reason for a liver transplant (4) . In the UK, it is estimated approximately 90000 patients present with paracetamol overdose a year, resulting in 50000 hospital admissions and 150-250 deaths (5) (6) (7) . The paracetamol reactive metabolite that is responsible for paracetamol-induced liver injury is N-acetyl-p benzoquinone imine (NAPQI). When a paracetamol overdose has been taken, the supply of cellular glutathione (GSH) is saturated and therefore less NAPQI is neutralised. In hepatocytes, NAPQI can form protein adducts with intracellular proteins, which can lead to mitochondrial dysfunction, nuclear DNA fragmentation, oxidative stress, hepatocyte death and subsequent acute liver failure, and potentially patient death (8, 9) . The major cell death pathway is necrotic, although some apoptotic cell death can also occur.
Xenopus laevis (the African clawed frog) can produce approximately 1000 embryos/day with hormonal stimulation. Following in vitro fertilisation, the embryos rapidly develop ex utero and are amenable for medium throughput small molecule screens. As part of these screens, it was noted that Xenopus embryos could highlight compound toxicity (10) (11) (12) . Consequently, as well as being useful to identify new drugs, Xenopus embryos may also represent a model for early phase pre-clinical drug toxicity studies during drug development. Previously, we have successfully used this model to help assess nanotoxicity for biomedically-relevant nanomaterials (13).
The Xenopus embryo shares similar advantages to another non-mammalian animal model, the zebrafish (Danio rerio) (14) . They are both easier to house and less expensive than mammalian animal models. However, unlike in zebrafish, not much work has been done to investigate the use of Xenopus embryos for the prediction of drug-induced toxicity.
Drug-induced liver injury (DILI) was investigated in order to begin to characterise the use of Xenopus embryos as a predictive tool for drug-induced toxicity. Paracetamol was used as the model hepatotoxin. Paracetamol-induced liver injury is dosedependent. Therefore it was hypothesised that the Xenopus laevis embryos would exhibit indications of paracetamol-induced liver injury that correlated with paracetamol dose exposure. Increasing paracetamol concentration exposure to the Xenopus embryos, correlated with an increased expression of the liver-specific biomarker miR-122 in tissue that does not include the liver, and a depletion of free GSH.
Results
Paracetamol exposure response in Xenopus laevis embryos Stage 38 Xenopus laevis embryos were exposed to paracetamol that was dissolved into the embryo incubation media. After a 72 h incubation period, the resulting stage 45 embryos showed a variety of phenotypes (Figure 1) . Untreated stage 45 Xenopus embryos were termed "wildtype". In the treatment group, the wildtype phenotype was less common with increasing paracetamol concentration. Of the embryos that were exposed to the Xenopus media only, 96% displayed a wildtype phenotype, which decreased to 24% for the embryos exposed to 5 mM paracetamol.
Phenotypes that deviated from the norm included damaged tail, oedema, abnormal gut and bent tail ( Figure 1A-E) . The incidence of all phenotypes that are different to the wildtype was larger with increasing paracetamol concentration from 4% to 46%, Xenopus media only to 5 mM paracetamol exposure respectively ( Figure 1F ).
Oedema typically occurred around the gastro-intestinal region of the embryo ( Figure   1C ). The percentage of stage 38 embryos that were exposed to 5 mM paracetamol and did not survive to the harvest age of stage 45 was 9% compared to the 4% incidence for the embryos exposed to Xenopus media only.
Free GSH content in Paracetamol Treated Embryos
In humans, the generation of the reactive metabolite, NAPQI, and the reduction of the neutralising agent, GSH, mediate paracetamol-induced liver injury. Consequently, the amount of free GSH can indicate the metabolism pathway of paracetamol and be an indirect measurement of paracetamol-induced liver injury. Existing in vivo or in vitro assays that imitate human paracetamol overdose and the associated acute liver failure, show a reduction of free GSH in the assay system (15) (16) (17) (18) .
Embryos at stage 38 were treated with a paracetamol concentration within the range 0-5 mM, harvested at stage 45, and processed to measure the amount of free GSH miR-122 is a marker for the liver in Xenopus embryos
The location of the liver is not always obvious in the Xenopus laevis embryo, it is <0.5 mm at its widest diameter, and the colour of it is not notably different to the intestines.
Thus, a probe was used to identify the liver using a wholemount in situ hybridisation The miR-122 expression levels were normalised to a miRNA (miR-103), which has been shown to not be affected by paracetamol treatment in rodents (25) . Similarly, the expression of miR-103 is not affected by paracetamol in Xenopus laevis 
Treatment with acetyl-meta-aminophenol (AMAP)
AMAP is supposedly the non-toxic regioisomer version of APAP, but this appears to be species-dependent (26) . The Xenopus response to AMAP was explored by looking at the effect of GSH depletion, which was determined by measuring the amount of free Xenopus incubation with the human clinical treatment for paracetamol overdose
In the clinic, patients are administered N-acetyl cysteine (NAC) to prevent severe paracetamol-induced liver injury. The NAC replenishes GSH stores, scavenges ROS in mitochondria and enhances the sulphation APAP metabolic pathway. The NAC therapeutic effect is more useful at preventing liver injury if it is taken less than 8 hours after the APAP overdose (27, 28) .
Xenopus embryos were co-incubated with 0.5 mM NAC and a concentration within the 0-5 mM APAP range. Initially, NAC and APAP were co-incubated in 2 conditions: (1) incubation of the stage 38 embryos with 0.5 mM NAC for 2h and then the APAP concentration was added to the media and (2) Embryos that were pre-incubated with NAC before the APAP addition, had a decrease in free GSH with increasing APAP concentration, however the gradient was smaller in
comparison to their counterparts that were treated with APAP only (Figure 6A ). The concurrent NAC and APAP co-incubation also had a negative correlation between free GSH and APAP concentration, but this gradient was (on average), smaller than the pre-incubation treatment. Both methods showed a trend where NAC reduced the effect of APAP on GSH, but this was not statistically significant.
Next, 0.5 mM NAC was added to APAP-treated embryos 24h, prior to their harvest at stage 45 (n=5) ( Figure 6B ). The free GSH measured in the embryos treated with NAC was (on average), higher than the counterpart embryos treated with the same APAP concentration compared with APAP alone. However, the amount of free GSH measured in NAC-treated embryos did decrease with increasing APAP concentration, though significantly less than in embryos treated with APAP alone.
Discussion
To our knowledge, the Xenopus laevis animal model has not been thoroughly assessed as a model to predict drug-induced toxicity. To begin to investigate the usefulness and limitations of Xenopus laevis embryos in this area, this research focused on the response to one known hepatotoxic drug, paracetamol. The results generated here suggest that Xenopus could be a suitable model to predict DILI.
The Xenopus liver has the same cell types as found in humans including hepatocytes, stellate cells, Kupffer cells and sinusoidal endothelial cells (29) . Similar to vertebrates, the liver is derived from the endoderm of the future gut tube, close to where the stomach and duodenum will meet (30) . By tadpole stage 37-39, the Xenopus liver is a sac-like structure, with thick walls that fold inwards and fills the liver cavity with hepatocytes. Also at this time, the liver and biliary ductal systems are developing and the gall bladder is a thin-walled sac structure (29) . 
Phenotype and GSH
The paracetamol concentration range 0-5 mM is consistent with the dose used to investigate paracetamol-induced liver injury in zebrafish in the literature. Furthermore, the gastrointestinal oedema phenotype in the Xenopus embryos was also observed in response to paracetamol in zebrafish larvae (31) . Similar to the Xenopus embryos, zebrafish larvae were exposed to soluble paracetamol in the media the embryos were swimming in. Furthermore, the zebrafish used to model paracetamol-induced hepatotoxicity were aged of 72-120 hpf which is close to the Xenopus embryo age used in the research presented here (31-34).
For paracetamol-induced liver injury in humans, the reduced amount of free GSH is part of the pathophysiology mechanism as it allows the accumulation of the reactive metabolite NAPQI. The reduction of free GSH observed in the Xenopus embryos 
miR-122
Xenopus miR-122 has the same nucleotide sequence as zebrafish, humans and rodents and the WISH results show that miR-122 is liver-specific in the Xenopus, much like these animal models as well (20, 35, 36) . The presence of miR-122 in the blood in humans is an indication of DILI. The Xenopus embryos have a circulatory system at the ages used in this work, but the size of the embryos is too small to be able to easily obtain a blood sample, and the volume of blood within the embryo is very little.
Consequently, in order to measure the expression of miR-122 with paracetamol treatment, it was decided to use the tail tissue to represent the blood or circulatory harvest. Of the 3 conditions performed, the 24h incubation prior to harvest is the most clinically relevant to humans. Embryos exposed to 1 mM paracetamol and then exposed to 0.5 mM NAC 24h prior to harvest, had an significantly higher amount of GSH compared to embryos that were only exposed to 1 mM paracetamol (meanSEM;
97.19.6 nmol/mg and 54.56.6 nmol/mg respectively). However in all the treatment conditions, the amount of free GSH measured is greater in the embryos of the NAC treatment group compared with the embryos without NAC, of the same paracetamol concentration group. This smaller decline of free GSH with NAC treatment suggests the embryos are metabolising paracetamol to generate a small molecule that depletes GSH, and that this pathway can be reversed through the administration of NAC. This rescue mechanism implies (but cannot confirm) that the reactive metabolite generated 
Conclusion
Overall the Xenopus embryo model appears to have the ability to react to paracetamol in a dose-dependent manner as shown by looking at GSH levels and also by observing the expression of the liver-specific biomarker miR-122 in the embryo. This is comparable to research undertaken using zebrafish (31) (32) (33) (34) . The depletion of GSH with paracetamol treatment suggests the Xenopus embryo metabolic pathway is similar to that observed in humans and rodent paracetamol-induced liver injury models.
To our knowledge, GSH reduction has not been measured in the zebrafish paracetamol-induced hepatotoxicity model. Going forward it would be interesting to confirm the mechanism of toxicity using a CYP450 inhibitor that is valid for Xenopus.
Furthermore, the CYP450 isoform that could be involved in the Xenopus metabolism of paracetamol should be determined. Although the dominant isoform in humans that generates the reactive metabolite NAPQI is the CYP2E1, in zebrafish the CYP3A65 isoform is predominantly responsible for NAPQI generation (37) . At stage 38 to stage 45, the Xenopus embryos express CYP2D6 and CYP3A4 as well as CYP2E1. In humans CYP2D6 and CYP3A4 are responsible for over 50 % of all drugs (38) . In summary, these results represent the initial steps towards determining the advantages
and limitations of the Xenopus embryo model as a predictive tool for DILI, and pave the way for future assessment of the value of Xenopus as an efficient and effective in vivo toxicity model for other organ systems.
Methods
All experiments were performed in compliance with the relevant laws and institutional guidelines at the University of East Anglia. This research has been approved by the local ethical review committee according to UK Home Office regulations. Xenopus embryo stages were identified according to Nieuwkoop & Faber (1994) (30) .
Xenopus laevis embryos develop at a rate that is proportional to the temperature at which they are incubated. Consequently, unlike the zebrafish, the age of a Xenopus embryo cannot be given in hours post fertilisation (hpf), instead, the age can be identified using the developmental stages set out by Nieuwkoop and Faber (these can also be found on the NIH-funded website xenbase.org) (30) . At 25°C, a Xenopus embryo can develop into an adult in 12 months, this is the temperature that elicits the fastest development rate. At <12°C the embryos will die however, between 12°C and 25°C, the embryos will develop at a rate proportional to the temperature. An incubation temperature of 23°C was used for all of the following experiments.
Embryo fixing
Once the embryos reached their desired stage they were fixed using MEMFA (3.7%
(v/v) formaldehyde, 1X MEM salts (0.1 M MOPS, 2 mM EGTA, 1 mM MgSO4, pH7.4) made up with dH2O. They were then dehydrated in 100 % ethanol (EtOH) and stored at -20°C.
RNA isolation and cDNA synthesis
After incubation until the stage required, 10 embryos were frozen in liquid nitrogen for at least 2 h. mRNA was isolated using the trizol method, miRNA was isolated using the miRCURY TM RNA Isolation (for tissue) kit according to manufacturer's instructions.
For miRNA, cDNA was generated using the Universal cDNA synthesis kit II (Exiqon).
qRT-PCR
The reaction was performed in MicroAmp optical 96 well plate (Applied Biosystems)., and purified using Illustra MicroSpin G-50 Columns (GE healthcare life sciences) according to manufacturer's instructions. Micro-RNA probes were obtained from
Exiqon. WISH was carried out as previously described (20, 39) Paracetamol treatment
Paracetamol (Sigma, UK) was dissolved in 0.1X MMR alone. Embryo age was determined according to Nieuwkoop & Faber (1994) (30) . For 1 biological replicate (n=1), we used 7 embryos for each drug concentration. Consequently 5 biological replicates (n=5) used a total of 35 embryos. 1 biological replicate is defined as using 1 adult frog mother. In other words, a result generated from embryos that have the same mother, was only counted as 1 biological replicate.
The preparation of samples for the measurement of miR-122 expression using qRT-PCR Stage 38 embryos were treated with paracetamol as described above until stage 45.
At stage 45, the embryos put into 0.5 mg/mL tricaine (0.1X MMR) and incubated at 23°C for 1 h. Embryos were dissected into tail and gut tissue using a simple razor blade. The dissection technique was confirmed by analyzing the expression of the liver-specific marker AMBP. AMBP was expressed in the gut tissue dissected but not in the tail tissue.
N-acetyl cysteine (NAC) and paracetamol
Pre-incubation
Stage 38 embryos were exposed to a final concentration of 0.5 mM NAC at 23°C for 2 h prior to paracetamol. This was incubated for a further 70 h, until the embryos were stage 45 at 23°C. The embryos were processed with the GSH assay method.
Concurrent treatment
Stage 38 embryos were exposed to a final concentration of 0.5 mM NAC and a paracetamol concentration within the range 0-5 mM paracetamol at 23°C for 72 h until 
h NAC treatment prior to harvest
Stage 38 embryos were exposed to paracetamol within the range 0-5 mM at 23°C for 48 h. At 48 h we added NAC to a final concentration of 0.5 mM and this was further incubated for 24 h at 23°C until the embryos were stage 45.
All the embryos were processed with the GSH assay method at stage 45.
Measuring free GSH
Sample preparation
At the end of the incubation period, embryos that were treated with the same conditions were pooled. As much as possible, the incubation solution was removed and the embryos were homogenized. The amount of free GSH was measured in the supernatant using a GloMax® Explorer System spectrophotometer (Promega) and quantified using the Bradford assay.
Statistical analysis
Statistical tests were carried out using GraphPad Prism 6.0 software. An ordinary oneway ANOVA was used for investigating the difference of the treated groups compared to the untreated embryos and Mann-Whitney non-parametric tests were used to compare unpaired treatment groups. Xenopus laevis embryos were exposed to 0-5 mM paracetamol from the age of stage 38, and harvested at stage 45 (A, n=10) or at stage 41 (B, n=3). The amount of free GSH (nmol/mL) was measured inside the embryos and normalised to the amount of protein (mg/mL). An ordinary one-way ANOVA compared each exposure group to the group exposed to Xenopus media alone (0 mM). For the embryos exposed until stage 45 (A), the amount of free GSH for 3, 3.5, 4 and 4.5 mM paracetamol exposure groups was statistically significant compared to the group exposed to Xenopus media only (P<0.05). The 5 mM paracetamol exposure group was also statistically significantly different (P<0.01). There was no significant difference between treated and untreated embryos that were harvested at stage 41 (B). Stage 38 embryos were exposed to paracetamol (0-5 mM) and harvested at stage 45.
The expression of miR-122 in the gut (purple) and tail (red) was measured using qRT-A C C E P T E D M A N U S C R I P T PCR (log (fold change ± SEM)) and normalised to embryos exposed to Xenopus media only (0 mM). The statistically significant difference of miR-122 expression between tissues from embryos treated with the same paracetamol concentration was measured using the Mann-Whitney test (P<0.05) (n=5). 
